Regeneron Pharmaceuticals Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| ABBV | AbbVie | Outperform |
9
|
$164.66 | $178.42 | 14.78% | 11 | $291.55B |
| VZ | Verizon Communications | Outperform |
6
|
$40.13 | $45.10 | 14.63% | 9 | $168.95B |
| CMCSA | Comcast Corp | Outperform |
10
|
$39.62 | $50.29 | 26.20% | 7 | $157.36B |
| PFE | Pfizer | Outperform |
2
|
$25.39 | $32.87 | 20.13% | 6 | $143.77B |
| AMGN | Amgen | Outperform |
4
|
$262.75 | $303.65 | 20.74% | 8 | $140.93B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$48.30 | $58.15 | 13.87% | 10 | $97.89B |
| GILD | Gilead Sciences Inc | Outperform |
11
|
$66.16 | $87.82 | 23.94% | 14 | $82.50B |
| 4519 | Chugai Pharmaceutical | Outperform |
6
|
¥5.09k | ¥4.92k | 20.83% | 0 | ¥8.37T |
| 2914 | Japan Tobacco | Hold |
6
|
¥4.08k | ¥3.25k | 0.61% | 0 | ¥7.23T |
| 4502 | Takeda Pharmaceutical Company | Outperform |
5
|
¥4.09k | ¥4.74k | 13.72% | 0 | ¥6.42T |
| ALC | Alcon | Outperform |
8
|
CHF72.12 | CHF90.64 | 33.61% | 3 | CHF35.57B |
| BIIB | Biogen | Outperform |
10
|
$190.52 | $299.62 | 53.26% | 13 | $27.69B |
| CE | Celanese | Hold |
13
|
$154.62 | $148.23 | 3.48% | 18 | $17.25B |
| BGNE | BeiGene | Buy |
6
|
$131.96 | $285.19 | 108.40% | 2 | $13.79B |
| INCY | Incyte | Outperform |
9
|
$52.82 | $77.05 | 46.16% | 8 | $11.86B |
| UTHR | United Therapeutics | Outperform |
12
|
$236.93 | $284.08 | 25.35% | 3 | $11.15B |
| JAZZ | Jazz Pharmaceuticals | Outperform |
14
|
$109.27 | $188.32 | 73.88% | 4 | $8.36B |
| IONS | Ionis Pharmaceuticals | Outperform |
9
|
$40.81 | $55.60 | 47.51% | 3 | $6.37B |
| EXEL | Exelixis | Outperform |
16
|
$22.49 | $26.44 | 20.05% | 5 | $6.21B |
| SPIE | SPIE | Outperform |
18
|
33.98€ | 32.33€ | 11.83% | 6 | 5.45€B |
| BHC | Bausch Health Companies | Hold |
15
|
$8.60 | $9.50 | 16.28% | 5 | $3.10B |
| MRUS | Merus N.V. | Buy |
6
|
$40.47 | $43.70 | 43.32% | 7 | $2.78B |
| GLPG | Galapagos NV | Hold |
6
|
27.38€ | 39.85€ | 32.40% | 2 | 2.42€B |
| 500674 | Sanofi India | Outperform |
18
|
Rp8.47k | Rp8.61k | 8.26% | 0 | Rp203.92B |
| 002773 | Chengdu Kanghong Pharmaceutica... | Buy |
11
|
¥17.18 | ¥24.00 | -100.00% | 1 | ¥15.24B |
| LGND | Ligand Pharmaceuticals | Outperform |
14
|
$72.52 | $111.83 | 51.68% | 3 | $1.56B |
| FYB | Formycon | Buy |
11
|
39.70€ | 106.60€ | 140.55% | 0 | 894.96€M |
| 4551 | Torii Pharmaceutical | Outperform |
14
|
¥3.78k | ¥4.04k | 15.23% | 0 | ¥109.48B |
| CHRS | Coherus BioSciences | Outperform |
6
|
$2.00 | $10.86 | 300.00% | 3 | $266.16M |
| OPTN | OptiNose | Buy |
6
|
$0.93 | $3.00 | 276.34% | 2 | $193.74M |
| ALIM | Alimera Sciences | Outperform |
9
|
$3.44 | $7.00 | 132.56% | 3 | $178.22M |
| MTNB | Matinas BioPharma Holdings | Buy |
7
|
$0.19 | $0.65 | 426.32% | 0 | $56.27M |
| IRIX | IRIDEX | Hold |
9
|
$3.02 | $2.00 | -33.77% | 0 | $42.41M |
| ACST | Acasti Pharma | Buy |
0
|
$3.07 | $16.34 | 162.54% | 0 | $28.76M |
| XBRANE | Xbrane Biopharma AB (publ) | Outperform |
5
|
kr0.36 | kr116.00 | 108.33% | 0 | kr22.92M |
| CDXI | Cardax | - |
0
|
$0.00 | $0.00 | 0.00% | 0 | $0.00M |